RapidPulse, Inc., founded as a spinout of Syntheon LLC., is a privately held medical device company focused on developing minimally invasive vascular products for treating ischemic stroke. The company's core mission is to innovate and improve stroke treatment outcomes through advanced medical technology. Their flagship product, the RapidPulse™ Cyclic Aspiration System, features a novel aspiration pump designed for the rapid and consistent removal of blood clots from the brain, targeting healthcare providers and patients in the stroke care market.
Notable affiliated individuals include experts from Syntheon LLC., who bring extensive experience in medical device innovation. RapidPulse has garnered attention for its significant achievements, including published research demonstrating superior First Pass Effect (FPE) TICI≥2c scores with their system compared to standard aspiration methods. The company’s impact lies in its potential to revolutionize stroke treatment, offering more effective solutions for a critical medical condition.
